PM&R
Volume 1, Issue 3 , Pages 254-260 , March 2009

A Review of Osteoporosis: Part I. Impact, Pathophysiology, Diagnosis and Unique Role of the Physiatrist

  • Gopi C. Kasturi, MD

      Affiliations

    • VA Central California Health Care System, Physical Medicine and Rehabilitation, Fresno, CA†
    • Corresponding Author InformationAddress correspondence to: G.C.K.
    • ,
  • David X. Cifu, MD

      Affiliations

    • McGuire Veterans Affairs Medical Center, Richmond, VA‡
    • ,
  • Robert A. Adler, MD

      Affiliations

    • McGuire Veterans Affairs Medical Center, Richmond, VA§

Received 21 August 2008 ,Accepted 9 December 2008.

References 

  1. Mauck KF, Clarke BL. Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc. 2006;81:662–672
  2. US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 2004;
  3. National Osteoporosis Foundation. NOF's new clinician's guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/Clinicians_Guide.htmAccessed July 21, 2008
  4. Kuehn BM. Better osteoporosis management a priority impact predicted to soar with aging population. JAMA. 2005;293:2453–2458
  5. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761–1767
  6. Adler RA. Epidemiology and pathophysiology of osteoporosis in men. Curr Osteoporos Rep. 2006;4:110–115
  7. Lenchik L, Rogers LF, Delmas PD, Genant HK. Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. Am J Roentgenol. 2004;183:949–958
  8. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Arch Intern Med. 1999;159:1215–1220
  9. Pluijm SM, Tromp AM, Smit JH, Deeg DJ, Lips P. Consequences of vertebral deformities in older men and women. J Bone Miner Res. 2000;15:1564–1572
  10. Adler RA. Epidemiology and pathophysiology of osteoporosis in men. Curr Osteoporos Rep. 2006;4:110–115
  11. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ. 1991;303:961–964
  12. O'Flaherty EJ. Modeling normal aging bone loss, with consideration of bone loss in osteoporosis. Toxicol Sci. 2000;55:171–188
  13. Raisz LG. Physiology and pathophysiology of bone remodeling. Clin Chem. 1999;45(8 Pt 2):1353–1358
  14. Parfitt A. What is the normal rate of bone remodeling?. Bone. 2004;35:1–3
  15. Overview of osteoporosis. In:  Bruder J,  Tanner SB,  Leib E,  Kendler D,  Binkley N editor. ISCD Bone Densitometry Clinician Course Syllabus and Associated Reading Materials. West Hartford, CT: The International Society for Clinical Densitometry; 2007;p. 10–23
  16. Kanis JA. FRAX WHO Fracture Risk Assessment Tool. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK http://www.shef.ac.uk/FRAX/index.htmAccessed July 22, 2008
  17. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. JAMA. 2002;288:1889–1897
  18. Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 2002;87:4431–4437
  19. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is Effective. Am J Clin Nutr. 2007;85:649–650
  20. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S–1086S
  21. Ivaska KK, Lenora J, Gerdhem P, Akesson K, Väänänen HK, Obrant KJ. Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab. 2008;93:2622–2632
  22. Hamdy RC. Our osteoporosis report card: ‘A’ for apathy, ‘D’ for effort, and ‘F’ for results. South Med J. 2004;97:538–539
  23. Johnson SL, Petkov VI, Williams MI, Via PS, Adler RA. Improving osteoporosis management in patients with fractures. Osteoporos Int. 2005;16:1079–1085
  24. Hajcsar EE, Hawker G, Bogoch ER. Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ. 2000;163:819–822
  25. Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum. 2002;47:651–654
  26. Juby AG, De Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int. 2002;13:205–210
  27. Khan SA, de Geus C, Holyroyd B, Russell AS. Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med. 2001;161:1309–1312
  28. Dreinhöfer KE, Anderson M, Féron JM, et al. Multinational survey of osteoporotic fracture management. Osteoporos Int. 2005;16:S44–S53
  29. Siris ES, Bilezikian JP, Rubin MR, et al. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003;88:3482–3486
  30. Gardner MJ, Flik KR, Mooar P, Lane JM. Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am. 2002;84-A:1342–1348
  31. Melton LJ, Thamer M, Ray NF, et al. Fractures attributable to osteoporosis: report for the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:16–23
  32. Simonelli C, Chen YT, Morancey J, Lewis AF, Abbott TA. Evaluation and management of osteoporosis following hospitalization for low impact fracture. J Gen Intern Med. 2003;18:17–22
  33. Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int. 2004;15:767–778
  34. Chami G, Jeys L, Freudmann M, Connor L, Siddiqi M. Are osteoporotic fractures being adequately investigated? (A questionnaire of GP & orthopaedic surgeons). BMC Fam Pract. 2006;7:7
  35. Mackey DC, Lui LY, Cawthon PM, et al. High-trauma fractures and low bone mineral density in older women and men. JAMA. 2007;298:2381–2388
  36. Sanders KM, Pasco JA, Ugoni AM, et al. The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res. 1998;13:1337–1342
  37. Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C. Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am. 2003;85-A:1837–1843
  38. Warriner A, Curtis JR, Saag KG. Challenges in defining and improving osteoporosis quality of care. Clin Exp Rheumatol. 2007;25(Suppl 47):142–146
  39. Simonelli C, Killeen K, Mehle S, Swanson L. Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc. 2002;77:334–338
  40. Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial (FIT Research Group). J Clin Endocrinol Metab. 2000;85:4118–4124
  41. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial (Vertebral Efficacy with Risedronate Therapy (VERT) Study Group). JAMA. 1999;282:1344–1352
  42. Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis (Vertebral Efficacy with Risedronate Therapy (VERT) Study Group). Osteoporos Int. 2000;11:83–91
  43. Bahl S, Coates PS, Greenspan SL. The management of osteoporosis following hip fracture: have we improved our care?. Osteoporos Int. 2003;14:884–888
  44. Streeten EA, Mohamed A, Gandhi A, et al. The inpatient consultation approach to osteoporosis treatment in patients with a fracture (Is automatic consultation needed?). J Bone Joint Surg Am. 2006;88:1968–1974
  45. Pazirandeh M. Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management?. J Contin Educ Health Prof. 2002;22:142–151
  46. Majumdar SR, Johnson JA, Lier DA, et al. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int. 2007;18:261–270
  47. van Helden S, Cauberg E, Geusens P, Winkes B, van der Weijden T, Brink P. The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guideline. J Eval Clin Pract. 2007;13:801–805
  48. Gardner MJ, Brophy RH, Demetrakopoulos D, et al. Interventions to improve osteoporosis treatment following hip fracture (A prospective, randomized trial). J Bone Joint Surg Am. 2005;87:3–7
  49. Davis JC, Guy P, Ashe MC, Liu-Ambrose T, Khan K. Hip watch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2007;62:888–891
  50. Gold DT, Silverman SL. Osteoporosis self-management: choices for better bone health. South Med J. 2004;97:551–554
  51. Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM. Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am. 2006;88:25–34
  52. Zerwekh JE, Ruml LA, Gottschalk F, Pak CY. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res. 1998;13:1594–1601
  53. Zehnder Y, Lüthi M, Michel D, et al. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men. Osteoporos Int. 2004;15:180–189
  54. Ramnemark A, Nyberg L, Lorentzon R, Englund U, Gustafson Y. Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke. Osteoporos Int. 1999;9:269–275
  55. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994;44:1687–1692
  56. Vaserman N. Parkinson's disease and osteoporosis. Joint Bone Spine. 2005;72:484–488
  57. Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int. 2000;11:400–407
  58. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis. 1995;54:801–806
  59. Lee JI, Kim JH, Kim HW, et al. Changes in bone metabolism in a rat model of traumatic brain injury. Brain Inj. 2005;19:1207–1211
  60. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain. 2002;3:377–384
  61. Boling EP. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis. Clin Ther. 2004;26:1–14

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

PII: S1934-1482(08)00084-1

doi: 10.1016/j.pmrj.2008.12.005

PM&R
Volume 1, Issue 3 , Pages 254-260 , March 2009

Article Tools